News

PhD candidate Raafiah Mussa (UCL Queen Square Institute of Neurology) co-writes an article in The Conversation about the many challenges stroke survivors face and calls for increased ongoing NHS care and psychological support.

The UCLB pharmaceutical spinout, EpilepsyGTx which is developing new treatments for refractory epilepsy, has raised $33 million USD (£24.78 million) in Series A funding to bring its gene therapy to clinical trials.

Five UCL academics have received prestigious European Union-funded grants to support research for the next five years in projects covering economics, criminal governance, and neuroscience.

UCL researchers have used advanced brain imaging to uncover the distinct brain changes between people with Parkinson’s disease and Lewy body dementia, opening the door to more targeted treatments

We're delighted that Dr Mena Farag (UCL Queen Square Institute of Neurology) was awarded the UK DRI PhD Prize on 9th December 2025 at Connectome 2025.

Professor Sarah Tabrizi (UCL Queen Square Institute of Neurology) has been named in Nature's 10 list, recognising the people involved in the most influential and important developments this year.